“The market at this point..(is) pretty much pricing in a soft landing, and pricing in that we have defeated inflation, and that the Fed will be able to lower rates without causing a bunch of harm to the economy”, said Liz Young Thomas, head of investment strategy at SoFi in New York.
Posts in category Economic Times
Sequent to absorb Viyash, giving 56 for 100 shares (28-09-2024)
In a stock exchange filing, Sequent Scientific said its board has approved a proposal to merge Viyash Life Sciences and its group companies, and its wholly owned subsidiary Sequent Research with it.
Rs 1,481-crore block deal in Nuvama Wealth (28-09-2024)
Europacific Growth Fund, Greater India Portfolio, Capri Global Holdings and Morgan Stanley Asia Singapore Pte were among the buyers in the deal. Shares of Nuvama Wealth Management rose 0.99% to close at Rs 6,837.15 on Friday.
Promoters sell stake in Shivalik Bimetal in a block deal (28-09-2024)
Aditya Birla Sun Life MF, Sundaram MF, HSBC MF, Franklin Templeton MF and India Acorn Fund were among the buyers in the deal. Shares of Shivalik Bimetal Controls gained 1.18% to close at Rs 624 on Friday.
Angel One settles front running case with Sebi (28-09-2024)
The regulator had undertaken a detailed investigation by certain entities from January 1,2021 to October 31,2022, who were consistently placing orders ahead of the big clients including Bharat Kanaiyalal Sheth Family Trust in the cash segment and were squaring off the same.
Promoters sell stake in Sterling and Wilson (28-09-2024)
Morgan Stanley Asia Singapore Pte, Citigroup Global Markets Mauritius and Societe Generale were among some of the buyers in the deal. Shares of Sterling and Wilson rose 1.63% to close at `652.90 on Friday.
KRN Heat Exchanger IPO subscribed 214x on final day of bidding (28-09-2024)
The IPO was a fresh issue of 1.55 crore shares that will fetch Rs 342 crore at the upper price band. The price band was between Rs 209 and Rs 220.
UBS picks 2 pharma stocks that are likely to give 23-26% returns (28-09-2024)
Ascribing sell ratings to Lupin, Dr Reddy’s Laboratories, Zydus Lifesciences and Aurobindo Pharma, the brokerage said the US generic market has been declining and the pace could worsen.
HDFC Life to raise Rs 1,500 crore through NCDs (28-09-2024)
Company’s capital raising committee (CRC) met on Friday to finalise commercial terms for the fundraising under this first tranche, the company said in a stock exchange announcement. In a previous board meeting in July, the insurer had authorised raising ₹2,000 crore through NCDs in one or more tranches.
Accenture revenue guidance lifts sentiment at IT counters (28-09-2024)
HCL Tech and Coforge gained 1.4% and 1.2%, respectively. Mphasis, Persistent Systems, Infosys and Tata Consultancy Services closed between 0.3% and 0.5% higher. Most of these shares traded 2-4% higher earlier in the day.